(10-334) Long-Term Impact of Bevacizumab, Aflibercept, and Ranibizumab for Ophthalmology Patients

Wednesday, December 7, 2022

11:00 AM – 12:00 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Drug Information/Drug Use Evaluation

Co-Author(s): Lyndsy Beckman, Kristen Fink, Kim Jiramongkolchai, Aisha Masood

Primary Author(s)

Sydney N. Hajimirsadeghi, PharmD
Pharmacy Resident
Kaiser Permanente Mid-Atlantic States, Maryland